Allay Therapeutics, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Organon Will Market Lilly’s Emgality, R

As venture capital financings for biopharmaceutical companies continues to head into record-breaking territory again in 2021, Illumina Ventures and Jeito Capital announced two new venture capital fund

Four new sources of venture capital for biotechnology companies were announced during the first half of May with more than $1.7bn in fresh funding for start-ups and growing early-stage firms. Abingwor